文献速递肥胖与代谢综合征性腺与生殖内分泌

接受肥胖治疗的儿童和青少年的身高与生长速度:一项前瞻性队列研究

Height and Growth Velocity in Children and Adolescents Undergoing Obesity Treatment: A Prospective Cohort Study.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该前瞻性队列研究纳入瑞典儿童肥胖治疗登记处(BORIS)1998至2020年的27997名3-18岁儿童,比较I级与II级肥胖的身高和生长速度,并评估肥胖治疗结局对生长速度的影响。结果显示肥胖严重程度与儿童期身高和生长速度正相关,I级肥胖男性生长突增减弱、II级肥胖男性生长突增缺失,良好治疗结局使3-9岁生长速度较低但10-13岁生长速度较高,最终身高在I级与II级肥胖间无差异。

要点

  • II级肥胖儿童平均比I级肥胖儿童更高。
  • I级肥胖男性生长突增减弱,II级肥胖男性生长突增缺失,女性模式相似但较轻。
  • 良好治疗结局者3-9岁生长速度低于 poor 结局者,10-13岁高于 poor 结局者。

核心结论

  • 肥胖严重程度与儿童期身高和生长速度正相关,预期青春期生长突增受损尤其在严重肥胖青少年中,因此I级与II级肥胖间最终身高无差异;成功的肥胖治疗不损害生长速度模式而是使其正常化。

研究设计与样本

  • 前瞻性队列研究,纳入瑞典儿童肥胖治疗登记处(BORIS)1998-2020年登记的3-18岁儿童,共27997人(平均年龄10.2±3.6岁)。

主要发现

  • II级肥胖个体在儿童期平均比I级肥胖个体更高。
  • 男性中I级肥胖观察到生长突增减弱,II级肥胖中生长突增缺失;女性呈现相似但较不明显的模式。
  • 与poor治疗结局相比,good治疗结局在3-9岁生长速度较低,在10-13岁生长速度较高。

关键数值与推荐

  • 肥胖治疗结局以BMI z评分变化分类:good为BMI z评分降低≥0.25,intermediate,poor为BMI z评分升高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Pediatric obesity affects endocrine conditions, which may alter growth. OBJECTIVE: This work aimed to investigate the effect of obesity severity and obesity treatment outcome on growth. METHODS: This prospective cohort study included children (aged 3-18 years) enrolled in the Swedish Childhood Obesity Treatment Register (BORIS) (1998-2020). Obesity was categorized as class I and class II obesity. Obesity treatment outcome was measured as body mass index (BMI) z score changes and categorized into good (BMI z score reduction of ≥0.25), intermediate, and poor (increasing BMI z score). Height for age z score, final height, and growth velocity were compared between class I and class II obesity. Further, the effect of obesity treatment outcome on growth velocity during 2-year follow-up was assessed. RESULTS: A total of 27 997 individuals (mean age 10.2 ± 3.6 years) were included. Individuals with class II obesity were on average taller than those with class I obesity during childhood. Among males, reduced growth spurt was observed in class I obesity, and even absent in class II obesity. Females exhibited a similar but less pronounced pattern. Good obesity treatment outcome yielded lower growth velocity at ages 3 to 9 years but higher growth velocity at ages 10 to 13 years compared to poor treatment outcome. CONCLUSION: Obesity severity is positively associated with height and growth velocity in childhood. A hampered growth spurt during puberty should be anticipated, particularly in adolescents with severe obesity. Therefore no difference in final height between class I and class II obesity is expected. Successful obesity treatment does not harm, but rather normalizes, the growth velocity pattern.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Putri RR, Danielsson P, Marcus C, et al. Height and Growth Velocity in Children and Adolescents Undergoing Obesity Treatment: A Prospective Cohort Study. J Clin Endocrinol Metab. 2023. PMID: 37453086. doi:10.1210/clinem/dgad419

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。